ANPCF - ANGLE PLC has opened up a major market opportunity with breast cancer partnership
(NewsDirect)
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) chiefexecutive Andrew Newland joins Thomas Warner from Proactive afterannouncing a development partnership with BioView.
The partnership will see the two firmsdevelop to create a circulating tumour cell (CTC) HER2 assay forbreast cancer that could ultimately enable hospitals worldwide toaccess technology that measures HER2 status in breast cancerpatients.
Newlands says it hasopened up "a major market opportunity" with the partnership.
Contact Details
Proactive UKLtd
Proactive UK Ltd
+44 20 7989 0813
Copyright (c) 2023 TheNewswire - All rights reserved.